Feb 2024: Mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP) therapy have shown potential in treating knee osteoarthritis (KOA) in China. A meta-analysis of randomized controlled studies lo...
A PET scan is a ray of hope in the fight against cancer. If your doctor suspects a case of cancer, they might use this imaging method for an accurate diagnosis. Read our informative guide to learn al...
Discover how immunotherapy can be your true friend in beating myeloma! Our blog provides simple insights into the power of immunotherapy for multiple myeloma. Don't miss out on this resource for a mo...
Stem cell transplantation is an effective treatment for multiple myeloma, a type of blood cancer. This procedure has shown promising results in improving the lives of those with multiple myeloma, off...
Nov 2023: Under Project Renewal, an Oncology Centre of Excellence (OCE) initiative aimed at updating labelling information for older oncology drugs to ensure information is clinically meaningful and...
August 2023: For metastatic colorectal cancer (mCRC) that has already been treated with fluoropyrimidine, oxaliplatin, and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS w...
August 2023: Dostarlimab-gxly (Jemperli, GlaxoSmithKline), followed by dostarlimab-gxly as a single agent, was approved by the Food and Drug Administration for the treatment of primary advanced or re...
Results from a big clinical trial show that adding blinatumomab (Blincyto) to the treatment of people with acute lymphoblastic leukaemia (ALL) who are in remission, even if there are no signs of their...
July 2023: Evidence from a small-scale clinical trial shows that myasthenia gravis, an autoimmune disorder of the nervous system, could be treated with a variation of CAR-T, an advanced blood can...
July 2023: The Food and Drug Administration cleared talazoparib (Talzenna, Pfizer, Inc.) with enzalutamide for homologous recombination repair (HRR) gene mutations in metastatic castration-resistant p...